Irritable bowel syndrome Survey in gastroenterological adult outpatients in China

Trial Identifier:	D1844R00004
Sponsor:	AstraZeneca
NCTID::	NCT02955316
Start Date:	February 2017
Primary Completion Date:	September 2017
Study Completion Date:	September 2017

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
China, Hubei	Wuhan, Hubei, China

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.